Skip to content

Clinical Study on the Effects of "Meijiajing Anti-Sensitivity Gum Care Toothpaste" in Inhibiting Dental Plaque and Reducing Gum Inflammation

Clinical Study on the Effects of “Meijiajing Anti-Sensitivity Gum Care Toothpaste” in Inhibiting Dental Plaque and Reducing Gum Inflammation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118672
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic gingivitis

Interventions

Control group:Control toothpaste
Experimental group:Meijiajing Sensitive Gum Care Toothpaste

Sponsors

Shanghai Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1.In good overall health with no significant systemic diseases and at least 20 detectable teeth. 2.Ages 18 to 70. 3.Presence of gingivitis (BOP% >= 50%, GI 2–3). 4.No other similar trials or studies were conducted concurrently.

Exclusion criteria

Exclusion criteria: 1.History of allergy to ingredients in the test toothpaste. 2.Medications currently being taken (e.g., antibiotics, metronidazole, etc.) that may affect test results, or individuals who habitually use mouthwash. 3.Used other antibacterial or anti-inflammatory toothpaste within the past 3 months. 4.Open cavities or mucosal lesions are present in the oral cavity. 5.Suffering from severe periodontitis. 6.Habits such as smoking and chewing betel nuts that adversely affect oral health. 7.Conditions such as diabetes and hypertension that may affect periodontal health. 8.Individuals with intellectual or other disabilities who are unable to independently perform oral hygiene maintenance such as brushing their teeth. 9.Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Gingival Index (GI);

Secondary

MeasureTime frame
Evaluation of the efficacy in inhibiting dental plaque;Evaluation of the efficacy in alleviating gum problems;

Countries

China

Contacts

Public ContactQian Chenghui

Shanghai Stomatological Hospital

qianchenghui1980@163.com+86 21 54668040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026